Observational studyRheumatology (Oxford, England)2022

Efficacy and safety of tocilizumab in Behçet's syndrome with refractory arterial lesions: a single-centre observational cohort study in China.

Hua Zhong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.